The tumor suppressor protein, p53, regulating expressions of several genes that are related to the DNA repair protein, cell cycle arrest, and apoptosis induction, plays a pivotal role in cell proliferation [1] . It has been found that the p53 gene is frequently inactivated in over 50% human malignancies by point mutation or allelic deletion [2] . However, the tumorsuppression function of p53 is lost in most tumors that express wildtype p53. Therefore, understanding how wildtype p53 loses its tumorsuppression function is one of the most important goals in molecular oncology.
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The tumor suppressor protein, p53, regulating expressions of several genes that are related to the DNA repair protein, cell cycle arrest, and apoptosis induction, plays a pivotal role in cell proliferation [1] . It has been found that the p53 gene is frequently inactivated in over 50% human malignancies by point mutation or allelic deletion [2] . However, the tumorsuppression function of p53 is lost in most tumors that express wildtype p53. Therefore, understanding how wildtype p53 loses its tumorsuppression function is one of the most important goals in molecular oncology.
The apoptosisstimulating proteins of p53 (ASPP) family, including ankyrinrepeat, SH3domain, and prolinerichregioncontaining protein, comprises three members, ASPP1, ASPP2, and iASPP, and has been identified as specific regulators of p53, p63, and p73mediated apoptosis [35] . Among them, ASPP1 and ASPP2 are common activators of p53 family members, and specifically stimulate the transactivation function of p53 family members by binding to their most conserved and homologous region, through which ASPP1 and ASPP2 promote the apoptosis function of p53 family members [68] .
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In contrast, iASPP, an inhibitory member of the ASPP family, shares extensive sequence similarity with the carboxyl terminus of ASPP1 and ASPP2. iASPP could compete with ASPP1 or ASPP2 for interaction with wildtype p53 due to its p53binding regions similar to ASPP, resulting in the repression of the proapoptotic function of ASPP1 and ASPP2. Also iASPP is regarded as an oncoprotein that cooperates with Ras, E1A, and E7, but not mutant p53, to transform cells in vitro [9, 10] . Furthermore, iASPP is evolutionarily conserved from worm to human [9] , suggesting that it play a pivotal role in cell functions, cell apoptosis and tumorigenesis.
Recently, it was reported that the deregulated expression of ASPP family members has been found in several human cancers. ASPP1 and ASPP2 were found to be downregulated in many kinds of tumors, such as acute lymphoblastic leukemia (ALL), breast cancer, lung cancer, and liver cancer [6, 7, 11] . However, iASPP expression is upregulated in human tumors such as acute leukemia [3] , breast carcinomas [12] , and liver cancer [13] . Furthermore, increased expression of iASPP also confers resistance to ultraviolet radiation and to cisplatininduced apoptosis [9] . Our previous research showed that iASPP is frequently upregulated in hepotacellular carcinoma (HCC) and the elevated iASPP expression contributes to tumor progression by promoting proliferative and antiapoptotic effects [13] . iASPP would be a valuable therapeutic target for the treatment of HCC by sensitizing the chemotherapeutic drugs and also be a useful prognostic marker for HCC.
However, there is the potentially toxic effect of knockdown of iASPP on host cells with wildtype p53 [14] , and it is difficult to establish a stable cell line with knockingdown iASPP. In the present study, we developed a lentiviral vector with inducible iASPP targeted shRNA expression and investigated the function of iASPP gene in HCC preliminarily.
The plasmids pLVTHM, pLVCTtTRKRAB, psPAX2 and pMD2GVSVG were obtained from Addgene.
Nucleotide sequences of shRNA were selected using BLOCKiT RNAi designer (Invitrogen, Carlsbad, CA; https: //rnaidesigner.invitrogen.com/rnaiexpress/). To generate shRNAexpressing plasmids, the stuffer DNA was removed from pLVTHM by I and I digestion and replaced with doublestranded oligos encoding the desired shRNA downstream of the tetOH1 region. pLVTHM containing shRNA was cut with I and I, and then the fragment containing the shRNA cassette was cloned to pLVCTtTRKRAB plasmid opened with I I. Target sequences are listed as follows: shiASPP, 5'CGCG AGAGACCTTGTAATTGCGCGGTCAAGAGCCGCGCAAT TACAAGGTCTCTAT3'(forward), 5'CGATAGAGACCTT G TAATTGCGCGGCTCTTGACCGCGCAATTACAAGGTCT CT3' (reverse); shNon, 5'CGCGAATTCTCCGAAC GTGT C ACGTTCAAGAGACGTGACACGTTCGGAGAATTTTTT AT3' (forward), 5'CGATAAAAAATTCTCCGAACGTGTC A CGT鄄 CTCTTGAACGTGACACGTTCGGAGAATT3'(reverse).
Lentiviruses were generated by cotransfecting 293T cells with 4 滋 g of shRNAencoding plasmid, 3 滋 g psPAX2, and 1 滋 g pMD2GVSVG plasmids using Lipofectamine2000 (Invitrogen). Growth media was exchanged 8 h after transfection and lentiviruscontaining supernatant was harvested 48 h and 72 h after transfection. Target cell lines were transduced with lentiviral vectorsmediated inducible RNAi at MOI = 5.
293T and HepG2 cell lines were purchased from ATCC and maintained at 37益 in an atmosphere containing 5% CO 2 in Dulbecco爷s modified Eagle爷s medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS, Invitrogen). All shRNAexpressing stable cell lines were cultured in DMEM supplemented with 10% Tetapproved FBS (Clontech, Mountain View, CA). shRNA expression was induced by culturing cells in the presence of the indicated concentrations of doxycycline (Sigma, St. Louis, MO) dissolved in deionized water for the indicated periods of time.
Total RNA was isolated from samples using RNeasy columns (Qiagen, Hilden, Germany) and treated with DNase prior to cDNA amplification. cDNA was synthesized using PrimeScript RT reagent Kit (TaKaRa, Otsu, Japan) according to manufacturer爷s instructions. mRNA levels were determined using SYBR Premix Ex Taq (TaKaRa) on ABI 7500 RealTime PCR Systems (Applied Biosystems, Carlsbad, CA). The primers used for detecting iASPP mRNA were as follows: 5'GCGCCAACTACTCTAT CGTG3' (forward) and 5'TGCAGATGACTGTGTCGT TG3' (reverse). Actin was used as an endogenous control to normalize for differences in the amount of total RNA in each sample: 5'CGTGGACATCCGTAAAGACC3' (forward) and 5'ACAT CTGCTGGAAGGTGGAC3' (reverse). Relative expression of genes was calculated and expressed as 2 驻 驻 CT , as described previously [15] .
Cells were harvested by scraping into icecold PBS and lysed using radioimmunoprecipitation assay (RIPA) buffer (150 mmol/L sodium chloride, 1% triton X100, 1% sodium deoxycholate, 0.1% SDS, 50 mmol/L TrisHCl, pH 7.5 and 2 mmol/L EDTA) supplemented with protease inhibitor cocktails (Shenneng Bocai Biotech, Shanghai, China). Following separation by denaturing gel electrophoresis, proteins were transferred to polyvinylidene fluoride (PVDF) membranes. After probing with antiiASPP (1: A total of approximately 5.0 伊 10 3 HCC cells infected with lentivirus were plated in 96well plates. After 24 h of incubation, cell proliferation was assessed by MTS assay every day for 5 days using CellTiter 96 Aqueous One Solution Reagent (Promega, Madison, WI) according to the manufacturer爷s instruction. All experiments were performed in triplicate. The cell proliferation curve was plotted using the relative absorbance at each time point.
Seventytwo h after lentiviral infection, the cells were mixed with cell culture medium containing 0.5% agar to a final concentration of 0.25%. One mL of the cell suspension were immediately plated in 24well plates coated with 0.5% agar (1 mL per well) in cell culture medium. The colonies were counted in triplicate 15 days after plating, and the number of colonies per 10 3 cells was calculated.
Detection of early apoptotic cells was performed with the annexin Vpropidium iodide (PI) detection kit (Mai Bio, Shanghai, China). Briefly, 1 伊 10 5 cells infected with lentivirus were treated with or without cisplatin (0.5 滋 g/mL) for 24 h, washed with phosphate buffered saline (PBS), incubated in the dark at 4益 with annexin VFITC and PI for 15 min, and then analyzed by a dualcolor flow cytometry (FACSCalibur, Becton Dickinson, Sunnyvale, CA). Cells that were annexin VFITC + (with translocation of phosphatidylserine from the inner to the outer leaflet of the plasma membrane) and PI (with intact cellular membrane) were considered as early apoptotic cells.
For the construction of iASPP targeted shRNAexpressing plasmid, the annealed doublestranded oligos encoding the desired shRNA was inserted into the pLVTHM between I and I restriction sites. The recombinant plasmid was verified by restriction endonuclease and DNA sequencing. Then the fragment containing the shRNA cassette was cut from the correct clone and cloned to pLVCTtTRKRAB plasmid opened with I I, which was designated as pLVCTHshiASPP and pLVCTHshNon, respectively (Figure 1) .
Figure 1 Analysis of plasmid DNA by restriction digestion and agarose gel electrophoresis
The recombinant plasmids were double digested with Fsp I and Msc I, and the digested fragments were separated by agarose gel electrophoresis to indentify the correct insert size. Lane 1, molecular weight marker (姿 /Hind III + EcoR I); Lane 2, pLVCT鄄 tTR鄄 KRAB; Lane 3, pLVTHM鄄 shiASPP; Lane 4, pLVCTH鄄 shiASPP; Lane 5, pLVCTH鄄 shNon. www.cjcsysu.cn
By subjecting HepG2 cells infected with the lentivirus
LVCTHshiASPP to doxycycline treatment, we demonstrated efficient drugcontrolled knockdown of both endogenous iASPP mRNA and protein expression as shown in Figure  2A and 2B. In contrast, iASPP expression was not affected by a scramble shRNAexpressing lentivirus LVCTHshNon.
Figure 2 Inducible down鄄 regulation of iASPP gene expression in HepG2 cells infected with lentivirus
HepG2 cells infected with lentivirus encoding shiASPP or shNon as indicated. Forty鄄 eight h after tranfection, cells were treated with or without doxycycline (1 滋 g/ mL) for 5 days, and the mRNA (A) and protein (B) levels of iASPP were detected by quantitative RT鄄 PCR and Western blot analysis, respectively. Dox, doxycycline.
To investigate whether or not iASPP expression is associated with human hepatocarcinogenesis, we first determined the effects of iASPP expression downregulated by shRNA on cell proliferation of HepG2 cells. Cell proliferation was evaluated by MTS assay daily for 5 days. As shown in Figure 3A , after treatment with doxycycline, proliferation of HepG2 cells infected with LVCTHshiASPP was inhibited and proliferation rate decreased by 59.1%.
Next, we explored whether repression of iASPP by shRNA affected colony formation of HCC cells in soft agar assays. HepG2 cells infected with LVCTHshiASPP or LVCTHshNon were plated into medium with soft agar at 72 h after transfection. Colony formation was assayed on the 15th day after seeding. As shown in Figure 3B , after the treatment of doxycycline, colony formation was significantly inhibited in the LVCTHshiASPP infected group but no significant inhibition in untreated or LVCTHshNon infected group. All these results showed that downregulation of lentiviral vectormediated doxycyclineinducible iASPP expression resulted in marked inhibition of HCC cell proliferation in vitro.
Cell apoptosis analysis by flow cytometry showed that the apoptotic rate significantly increased by (10.2 依 2.4)% in LVCTHshiASPP group compared with LVCTHshNon group in HepG2 cells infected with lentivirus after treatment with doxycycline in combination with cisplatin treatment ( < 0.05, Figure 4) . The results suggested that the expression of iASPP gene in HCC cells may play an inhibitory effect on the cellular response to chemotherapyinduced apoptosis. HepG2 cells were infected with lentivirus encoding shiASPP or shNon for 72 h, and then were cultured in the cell media with or without doxycyclin (1 滋 g/mL) as indicated. A, cell proliferation was assessed every day for 5 days using MTS assay according to the manufacturer爷s instruction. The cell proliferation curve was plotted using the absorbance results relative to the value on day 1 for each group at each time point. B, soft agar colony assays were used to evaluate the potential of colony formation in vitro. The colonies were counted in triplicate 15 days after plating, and the columns show the mean number of colonies per 10 3 cells calculated (right). The numbers represent the mean of three independent experiments 依 standard deviation (SD). Photographs are representative images from each group as indicated under microscope (left). * P < 0.05.
Figure 4 The knockdown of iASPP expression promotes cell apoptosis in human HCC cells treated with chemotherapeutic drug
HepG2 cells were infected with lentivirus for 72 h, then were cultured in the cell media with or without doxycyclin (1 滋 g/mL), as indicated, for 4 days before treated with 0.5 滋 g/mL cisplatin for another 24 h. The percentage of apoptotic cells were detected by fluorescence flow cytometry with annexin V and propidium iodide (PI) staining. The columns show the average number of apoptotic cells (right). The experiments were repeated three times. * P < 0.05. iASPP is an inhibitory member of ASPP family, which are unified by their protein structure, containing four ankyrin repeats, an SH3 domain, and a prolinerich region at their C terminus [4] . Recently, it was reported that the expression of iASPP is frequently upregulated in various human tumors, such as breast carcinoma, acute leukaemia, HCC, and so on. As a negative regulator on p53activating apoptosis, iASPP may be a good candidate target gene in cancer therapy [16] . As reported previously, inhibition of iASPP mediated by RNA interference technology enhanced the sensitivity of tumor cells to ultraviolet radiation and chemotherapeutic drugs [9] .
LVCTH鄄 shNon
Due to the potentially toxic effects of iASPP gene knockdown on host cells with wildtype p53, it has been difficult to establish a stable cell line with iASPP gene knockdown. In the present study, we developed a lentiviral vector that contained all components of the teton system and the iASPP gene targeted shRNA, whose expression was observed with low background activity unless the addition of doxycycline. This system will be particularly suitable for studies that examine the biological function of iASPP and other genes coding for proteins that are toxic to host cells.
Our data in this paper showed that lentiviral vectormediated shRNA interference targeting iASPP suppressed the cell proliferation and reduced the number of colonies in a colony formation assay, which suggested that iASPP may contribute to the tumorigenesis. As a key inhibitor of p53, iASPP has been demonstrated to inhibit apoptosis mediated by p53 in several different types of cells 10] . Then the antiapoptotic role of iASPP in our study system was examined in HCC cell lines, and the results also showed that the knockdown of iASPP gene increased cell apoptosis slightly in HCC cell line (data not shown), while the number of apoptotic cells significantly increased in the presence of chemotherapeutic drugs. Further studies will be required to dissect the growth inhibition and proapoptosis function and mechanism of iASPP knockdown in human cancer cells. Taken together, our results provide a novel lentiviral system for druginducible knockdown of iASPP gene, and also suggest that iASPP may be a potential target for gene therapy in the future.
